TW262387B - - Google Patents

Info

Publication number: TW262387B
Authority: TW; Taiwan
Prior art keywords: active substance; core; aperture; exposed; release
Prior art date: 1991-11-13

Application number

TW081109348A

Other languages

Original Assignee

Glaxo Canada

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-13

Filing date

1992-11-23

Publication date

1995-11-11

1991-11-13 Priority claimed from GB919124106A external-priority patent/GB9124106D0/en

1991-11-13 Priority claimed from GB919124108A external-priority patent/GB9124108D0/en

1992-03-12 Priority claimed from GB929205463A external-priority patent/GB9205463D0/en

1992-11-23 Application filed by Glaxo Canada filed Critical Glaxo Canada

1995-11-11 Application granted granted Critical

1995-11-11 Publication of TW262387B publication Critical patent/TW262387B/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Molding Of Porous Articles (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
Container, Conveyance, Adherence, Positioning, Of Wafer (AREA)
Seal Device For Vehicle (AREA)

TW081109348A 1991-11-13 1992-11-23 TW262387B (zh)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB919124106A GB9124106D0 (en)	1991-11-13	1991-11-13	Device
GB919124108A GB9124108D0 (en)	1991-11-13	1991-11-13	Device
GB929205463A GB9205463D0 (en)	1992-03-12	1992-03-12	Device

Publications (1)

Publication Number	Publication Date
TW262387B true TW262387B (zh)	1995-11-11

Family

ID=27265924

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW081109348A TW262387B (zh)	1991-11-13	1992-11-23

Country Status (15)

Country	Link
US (1)	US5342627A (zh)
EP (1)	EP0542364B1 (zh)
JP (2)	JP3768247B2 (zh)
AT (1)	ATE133331T1 (zh)
AU (1)	AU658942B2 (zh)
CA (1)	CA2082740C (zh)
CZ (1)	CZ337392A3 (zh)
DE (1)	DE69207863T2 (zh)
DK (1)	DK0542364T3 (zh)
ES (1)	ES2083074T3 (zh)
GR (1)	GR3019431T3 (zh)
IL (1)	IL103723A0 (zh)
NO (1)	NO924372L (zh)
NZ (1)	NZ245100A (zh)
TW (1)	TW262387B (zh)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5398850A (en)	1993-08-06	1995-03-21	River Medical, Inc.	Gas delivery apparatus for infusion
DE4341442C2 (de) *	1993-12-04	1998-11-05	Lohmann Therapie Syst Lts	Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE4431653C2 (de) *	1994-09-06	2000-01-20	Lohmann Therapie Syst Lts	Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US5700245A (en)	1995-07-13	1997-12-23	Winfield Medical	Apparatus for the generation of gas pressure for controlled fluid delivery
US5773031A (en) *	1996-02-27	1998-06-30	L. Perrigo Company	Acetaminophen sustained-release formulation
US6110500A (en) *	1998-03-25	2000-08-29	Temple University	Coated tablet with long term parabolic and zero-order release kinetics
EP1095650A1 (en) *	1999-10-29	2001-05-02	Universiteit Leiden	Double phase time-controlled release system
US6569152B2 (en)	2000-03-21	2003-05-27	Farrington Pharmaceuticals, Llc	Sustained release delivery systems for solutes
CA2359812C (en) *	2000-11-20	2004-02-10	The Procter & Gamble Company	Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
MXPA03005339A (es) *	2000-12-14	2004-03-26	Johnson & Johnson	Productos de hormona esteroide que comprenden un agente de estabilizacion en forma no cristalina.
US6960357B2 (en)	2001-05-25	2005-11-01	Mistral Pharma Inc.	Chemical delivery device
ATE507816T1 (de) *	2001-11-14	2011-05-15	Durect Corp	Injizierbare depotzusammensetzungen und deren verwendung
US20070196415A1 (en) *	2002-11-14	2007-08-23	Guohua Chen	Depot compositions with multiple drug release rate controls and uses thereof
KR20040058101A (ko)	2001-11-14	2004-07-03	알자 코포레이션	카테터 주입가능한 데포 조성물 및 그의 용도
USD481456S1 (en)	2002-01-30	2003-10-28	Smithkline Beecham P.L.C.	Capsule
GB0203296D0 (en) *	2002-02-12	2002-03-27	Glaxo Group Ltd	Novel composition
US7125563B2 (en) *	2002-04-12	2006-10-24	Dava Pharmaceuticals, Inc.	Sustained release pharmaceutical preparations and methods for producing the same
US20040001889A1 (en)	2002-06-25	2004-01-01	Guohua Chen	Short duration depot formulations
US8637512B2 (en) *	2002-07-29	2014-01-28	Glaxo Group Limited	Formulations and method of treatment
PL213565B1 (pl) *	2002-07-29	2013-03-29	Glaxo Group Ltd	Preparat o przedluzonym uwalnianiu zawierajacy lamotrygine
AU2002359397B2 (en) *	2002-07-31	2009-01-29	Durect Corporation	Injectable depot compositions and uses thereof
BR0313539A (pt) *	2002-07-31	2005-06-21	Alza Corp	Composições depósito de polìmero multimodais injetáveis e seus usos
US20040068000A1 (en) *	2002-10-02	2004-04-08	Mintong Guo	Compression coated tablets
GB0400452D0 (en) *	2004-01-09	2004-02-11	Norton Healthcare Ltd	A pharmaceutical composition
US20050163847A1 (en) *	2004-01-21	2005-07-28	Andrx Pharmaceuticals, Llc	Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
GB0403628D0 (en) *	2004-02-18	2004-03-24	Arrow Group Ltd	Compression-coated tablets and the manufacture thereof
WO2006078320A2 (en)	2004-08-04	2006-07-27	Brookwood Pharmaceuticals, Inc.	Methods for manufacturing delivery devices and devices thereof
GB0423964D0 (en) *	2004-10-28	2004-12-01	Jagotec Ag	Dosage form
US20060142234A1 (en) *	2004-12-23	2006-06-29	Guohua Chen	Injectable non-aqueous suspension
WO2007073702A2 (es)	2005-12-29	2007-07-05	Osmotica Corp.	Comprimido multicapa con combinación de triple liberación
US8691272B2 (en) *	2005-12-30	2014-04-08	Intelgenx Corp.	Multilayer tablet
DE102007026037A1 (de)	2007-06-04	2008-12-11	Lts Lohmann Therapie-Systeme Ag	Gastroretentives System mit Alginat-Körper
JP5502751B2 (ja)	2007-12-20	2014-05-28	エボニックコーポレイション	低残留溶媒濃度を有する微粒子を調製するためのプロセス
WO2010017821A1 (en) *	2008-08-14	2010-02-18	Daniel Bar-Shalom	Coated tablets with a remaining degradation surface over the time8
WO2010096820A1 (en) *	2009-02-23	2010-08-26	Eurand, Inc.	Controlled release compositions comprising anti-cholinergic drugs
US20110136815A1 (en) *	2009-12-08	2011-06-09	Horst Zerbe	Solid oral film dosage forms and methods for making same
US10610528B2 (en)	2009-12-08	2020-04-07	Intelgenx Corp.	Solid oral film dosage forms and methods for making same
CA2792523C (en) *	2010-03-09	2018-01-09	Alkermes Pharma Ireland Limited	Alcohol resistant enteric pharmaceutical compositions
EP2651399A2 (en)	2010-12-13	2013-10-23	Purdue Pharma LP	Controlled release dosage forms
CA2931547A1 (en)	2013-12-09	2015-06-18	Durect Corporation	Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
US9988669B2 (en)	2014-04-14	2018-06-05	Abbott Molecular Inc.	Medium used for blood sample collection and transport
CA3018328A1 (en)	2014-10-31	2016-04-30	Purdue Pharma	Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en)	2018-11-19	2020-07-28	Purdue Pharma L.P.	Methods and compositions particularly for treatment of attention deficit disorder
US12163326B1 (en) *	2019-10-01	2024-12-10	NeverClog, LLC	System for capturing and destroying hair or waste within a commercial shower drain
KR20220140711A (ko)	2020-01-13	2022-10-18	듀렉트 코퍼레이션	불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US480076A (en) *		1892-08-02		Thomas p
US3113076A (en) *	1956-07-03	1963-12-03	Henry R Jacobs	Medicinal tablets
GB1022171A (en) *	1961-06-15	1966-03-09	Wellcome Found	Prolonged release oral pharmaceutical tablets and their manufacture
US3851648A (en) *	1973-10-11	1974-12-03	Mead Johnson & Co	Zero-order release device
US4816262A (en) *	1986-08-28	1989-03-28	Universite De Montreal	Controlled release tablet
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance

1992
- 1992-11-10 DK DK92203447.5T patent/DK0542364T3/da active
- 1992-11-10 EP EP92203447A patent/EP0542364B1/en not_active Expired - Lifetime
- 1992-11-10 ES ES92203447T patent/ES2083074T3/es not_active Expired - Lifetime
- 1992-11-10 DE DE69207863T patent/DE69207863T2/de not_active Expired - Lifetime
- 1992-11-10 AT AT92203447T patent/ATE133331T1/de not_active IP Right Cessation
- 1992-11-11 AU AU28272/92A patent/AU658942B2/en not_active Ceased
- 1992-11-12 NZ NZ245100A patent/NZ245100A/en unknown
- 1992-11-12 US US07/975,079 patent/US5342627A/en not_active Expired - Lifetime
- 1992-11-12 NO NO92924372A patent/NO924372L/no unknown
- 1992-11-12 CA CA002082740A patent/CA2082740C/en not_active Expired - Lifetime
- 1992-11-12 CZ CS923373A patent/CZ337392A3/cs unknown
- 1992-11-12 IL IL103723A patent/IL103723A0/xx unknown
- 1992-11-13 JP JP32843092A patent/JP3768247B2/ja not_active Expired - Lifetime
- 1992-11-23 TW TW081109348A patent/TW262387B/zh active
1996
- 1996-03-27 GR GR960400817T patent/GR3019431T3/el unknown
2004
- 2004-03-12 JP JP2004071512A patent/JP4166716B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2082740A1 (en)	1993-05-14
NO924372D0 (no)	1992-11-12
ES2083074T3 (es)	1996-04-01
ATE133331T1 (de)	1996-02-15
GR3019431T3 (en)	1996-06-30
JP4166716B2 (ja)	2008-10-15
DE69207863T2 (de)	1996-06-05
JP2004189754A (ja)	2004-07-08
IL103723A0 (en)	1993-04-04
DK0542364T3 (da)	1996-03-11
CA2082740C (en)	2003-10-14
EP0542364B1 (en)	1996-01-24
CZ337392A3 (en)	1993-10-13
NO924372L (no)	1993-05-14
AU658942B2 (en)	1995-05-04
JP3768247B2 (ja)	2006-04-19
NZ245100A (en)	1995-06-27
EP0542364A1 (en)	1993-05-19
JPH05262640A (ja)	1993-10-12
US5342627A (en)	1994-08-30
DE69207863D1 (de)	1996-03-07
AU2827292A (en)	1993-05-20

Publication	Publication Date	Title
TW262387B (zh)	1995-11-11
CA2134885A1 (en)	1993-12-09	Reduced odor fragrance sampler
DE68905850D1 (de)	1993-05-13	Zusammensetzung zur beschichtung der aussenoberflaeche von sportbaellen und so erhaltene baelle.
DE60139631D1 (de)	2009-10-01	Riechstoffzusammensetzung
ITMI922617A1 (it)	1994-05-17	Forme matriciali multistrato per il rilascio controllato di principi attivi
GR3034737T3 (en)	2001-01-31	Device for effecting the controlled release of active substances
FR2622799B1 (fr)	1991-11-29	Forme de dosage pharmaceutique a liberation controlee et procede pour sa preparation
DE60027608D1 (de)	2006-06-01	Mesalazine enthaltende pharmazeutische Zusammensetzungen mit gesteuerter Freisetzung
ES2049414T3 (es)	1994-04-16	Dispositivo de administracion.
DE58901990D1 (de)	1992-09-10	Feste pharmazeutische retardform.
EP0325575A3 (en)	1990-08-29	Device for stabilizing an illuminated mask
MY106930A (en)	1995-08-30	Controlled release device
ES8601756A1 (es)	1985-11-01	Metodo de fabricar una estructura compuesta coherente.
DE59007252D1 (de)	1994-10-27	Thermotransferfolie zur Direktbebilderung eines Druckformzylinders.
ATE212543T1 (de)	2002-02-15	Pharmazeutische zusammensetzung aus stabilisierten lipophilen matrizen mit kontrollierter wirkstofffreisetzung
DK179090A (da)	1990-09-20	Anordning til intraruminal indgivelse af medikamenter
TH16921A (th)	1995-11-23	อุปกรณ์การปลดปล่อยชนิดควบคุม
JPS55140592A (en)	1980-11-04	Preparation of support body for lithography plate
JPS6473332A (en)	1989-03-17	Image forming method
ITBO930460A0 (it)	1993-11-12	Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.
FR2662446B1 (fr)	1994-06-17	Encre de clicherie en plaque pour fabrication de tampons marqueurs pre-encres.